ArticlePublic health in practice (Oxford, England)2022

Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly population.

M A Kundro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.